3 Stocks with robust net profit growth of up to 77% in Q4 FY25 to keep on your radar
This month, many new companies have announced their financial results. And the results are gathering mixed reactions from the Dalal Street as many known companies are failing to perform as per the street’s expectations. In this article, we will discuss three companies that posted a superior growth of above 50% in its YoY profit after […] The post 3 Stocks with robust net profit growth of up to 77% in Q4 FY25 to keep on your radar appeared first on Trade Brains.


This month, many new companies have announced their financial results. And the results are gathering mixed reactions from the Dalal Street as many known companies are failing to perform as per the street’s expectations. In this article, we will discuss three companies that posted a superior growth of above 50% in its YoY profit after tax.
1. Dr Lal Pathlabs
Dr. Lal PathLabs Limited, which was established in 1949 and has headquarters in Gurugram, runs diagnostic labs in India and outside India. The company provides an extensive variety of pathological tests under disciplines such as biochemistry, hematology, microbiology, immunology, virology, and radiology. In addition to its medical diagnostic operations, the company also runs training programs.
It reported a consolidated revenue of Rs 2,461 crores in FY25, up by 10.5 percent from its FY24 revenue of Rs 2,227 crores. Additionally, on a QoQ basis, it rose by 1 percent from 597 crores in Q3 FY25 to 603 crores in Q4 FY25. It increased by 10.64 percent YoY from 545 crores in Q4 FY24 to 603 crores in Q4 FY25.
It posted a net profit of Rs 492 crores in FY25, up by 35.91 percent, from its FY24 net profit of Rs 362 crores. Additionally, on a QoQ basis, it rose by 59.18 percent from 98 crores in Q3 FY25 to 156 crores in Q4 FY25. It increased by 81.40 percent YoY from 86 crores in Q4 FY24 to 156 crores in Q4 FY25.
2. Indiamart Intermesh
IndiaMART InterMESH Limited, incorporated in 1999 and having its headquarters in Noida, runs an online B2B marketplace to connect buyers and suppliers within India and overseas. Its platform is accessible to small and medium businesses, large business firms, and individual users, and provides a trading hub for business products and services.
It reported a consolidated revenue of Rs 1,388 crores in FY25, up by 16 percent from its FY24 revenue of Rs 1,197 crores. Additionally, on a QoQ basis, it rose by 0.28 percent from 354 crores in Q3 FY25 to 355 crores in Q4 FY25. It increased by 12.70 percent YoY from 315 crores in Q4 FY24 to 355 crores in Q4 FY25.
It posted a net profit of Rs 551 crores in FY25, up by 65 percent, from its FY24 net profit of Rs 334 crores. Additionally, on a QoQ basis, it rose by 50 percent from 121 crores in Q3 FY25 to 181 crores in Q4 FY25. It increased by 81 percent YoY from 100 crores in Q4 FY24 to 181 crores in Q4 FY25.
Also read: 1:2 Stock Split: 2 Stocks in focus after setting record date for share split in May
3. Tanfac Industries
Tanfac Industries Limited, established in 1972 and headquartered in Tamil Nadu, produces and markets fluorine-based chemicals in India and exports internationally. Its products include hydrofluoric acid (anhydrous and dilute), sulphuric acid, oleum, aluminium and potassium fluoride, boron trifluoride complexes, acetic and peracetic acid, and poly aluminium chloride.
It reported a consolidated revenue of Rs 557 crores in FY25, up by 47.37 percent from its FY24 revenue of Rs 378 crores. However, on a QoQ basis, it declined by 3.37 percent from 178 crores in Q3 FY25 to 172 crores in Q4 FY25. It increased by 67 percent YoY from 103 crores in Q4 FY24 to 172 crores in Q4 FY25.
It posted a net profit of Rs 88 crores in FY25, up by 69.23 percent, from its FY24 net profit of Rs 52 crores. However, on a QoQ basis, it declined by 34.29 percent from 35 crores in Q3 FY25 to 23 crores in Q4 FY25. It increased by 77 percent YoY from 13 crores in Q4 FY24 to 23 crores in Q4 FY25.
Written by Satyajeet Mukherjee
Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 3 Stocks with robust net profit growth of up to 77% in Q4 FY25 to keep on your radar appeared first on Trade Brains.
What's Your Reaction?






